Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection.
Tsantrizos YS, Bolger G, Bonneau P, Cameron DR, Goudreau N, Kukolj G, LaPlante SR, Llinàs-Brunet M, Nar H, Lamarre D
Angew. Chem. Int. Ed. Engl.
2003-03-28
;42(
12
):1356-60